Obsidian Therapeutics
ID: 5290137Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| St*** Sh**** |
|
- | |
| Ta*** Ka**** |
|
- | |
| Mi***** Gi**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Gi**** | - | - |
Funding series
Funding Series Analysis
The company Obsidian Therapeutics has raised a total of $115m in funding over 2 rounds.
Key Insights:
- Obsidian Therapeutics Series B round, September 9, 2021: $115m
- Obsidian Therapeutics Series A round, December 2017: $49.5m
Industries
Obsidian Therapeutics is active in the following industries: